
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE530D4A8AEE9F83050D4A004EC3C5E6.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="edm">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364101/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Endocrinology, Diabetes &amp; Metabolism">
<meta name="citation_title" content="Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study">
<meta name="citation_author" content="Nobutoshi Fushimi">
<meta name="citation_author_institution" content="Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan">
<meta name="citation_author" content="Hiroki Hachiya">
<meta name="citation_author_institution" content="Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan">
<meta name="citation_author" content="Tatsuya Iwasaka">
<meta name="citation_author_institution" content="Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan">
<meta name="citation_author" content="Machi Nagao">
<meta name="citation_author_institution" content="Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan">
<meta name="citation_author" content="Tomoki Masamura">
<meta name="citation_author_institution" content="Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan">
<meta name="citation_author" content="Kohei Higashi">
<meta name="citation_author_institution" content="Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan">
<meta name="citation_author" content="Akihiro Mori">
<meta name="citation_author_institution" content="Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="8">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="e70096">
<meta name="citation_doi" content="10.1002/edm2.70096">
<meta name="citation_pmid" content="40828947">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364101/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364101/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364101/pdf/EDM2-8-e70096.pdf">
<meta name="description" content="Glucotoxicity exacerbates hyperglycemia by impairing insulin secretion and sensitivity, necessitating effective interventions. Although short‐term intensive insulin therapy (SIIT) mitigates glucotoxicity, the effect of combining SIIT with ...">
<meta name="og:title" content="Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Glucotoxicity exacerbates hyperglycemia by impairing insulin secretion and sensitivity, necessitating effective interventions. Although short‐term intensive insulin therapy (SIIT) mitigates glucotoxicity, the effect of combining SIIT with ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364101/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12364101">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/edm2.70096"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/EDM2-8-e70096.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12364101%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12364101/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12364101/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364101/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-edm.jpg" alt="Endocrinology, Diabetes &amp; Metabolism logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Endocrinology, Diabetes &amp; Metabolism" title="Link to Endocrinology, Diabetes &amp; Metabolism" shape="default" href="https://onlinelibrary.wiley.com/journal/23989238" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Endocrinol Diabetes Metab</button></div>. 2025 Aug 19;8(5):e70096. doi: <a href="https://doi.org/10.1002/edm2.70096" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/edm2.70096</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Endocrinol%20Diabetes%20Metab%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Endocrinol%20Diabetes%20Metab%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Endocrinol%20Diabetes%20Metab%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Endocrinol%20Diabetes%20Metab%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fushimi%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Nobutoshi Fushimi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Nobutoshi Fushimi</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fushimi%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nobutoshi Fushimi</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hachiya%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Hiroki Hachiya</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Hiroki Hachiya</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hachiya%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hiroki Hachiya</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Iwasaka%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Tatsuya Iwasaka</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Tatsuya Iwasaka</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Iwasaka%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tatsuya Iwasaka</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nagao%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Machi Nagao</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Machi Nagao</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nagao%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Machi Nagao</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Masamura%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Tomoki Masamura</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Tomoki Masamura</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Masamura%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tomoki Masamura</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Higashi%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Kohei Higashi</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Kohei Higashi</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Higashi%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kohei Higashi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mori%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Akihiro Mori</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Akihiro Mori</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mori%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Akihiro Mori</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="edm270096-aff-0001">
<sup>
<sup>1</sup>
</sup>Department of Endocrinology and Diabetes, Ichinomiyanishi Hospital, Ichinomiya, Japan</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Nobutoshi Fushimi (<span>nobutoshi243@yahoo.co.jp</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 28; Received 2025 Apr 26; Accepted 2025 Aug 2; Collection date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Endocrinology, Diabetes &amp; Metabolism</em> published by John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12364101  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40828947/" class="usa-link">40828947</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="edm270096-sec-0001"><h3 class="pmc_sec_title">Aims/Introduction</h3>
<p>Glucotoxicity exacerbates hyperglycemia by impairing insulin secretion and sensitivity, necessitating effective interventions. Although short‐term intensive insulin therapy (SIIT) mitigates glucotoxicity, the effect of combining SIIT with sodium‐glucose co‐transporter 2 (SGLT2) inhibitors in hospitalised type 2 diabetes mellitus (T2DM) patients with severe hyperglycemia remains unclear. Herein, we aimed to evaluate the efficacy and safety of combining SGLT2 inhibitors with basal bolus therapy (BBT) for glycemic control in hospitalised patients with T2DM.</p></section><section id="edm270096-sec-0002"><h3 class="pmc_sec_title">Materials and Methods</h3>
<p>In this randomised, open‐label, single‐centre trial, 35 eligible T2DM patients hospitalised for treating hyperglycemia were allocated to the BBT (<em>n</em> = 17) or BBT with empagliflozin (BBT + E) groups (<em>n</em> = 18). Patients were monitored for 7 days using flash glucose monitoring. The primary outcome was time‐in‐range (TIR, 70–180 mg/dL). The secondary outcomes included time‐above‐range (TAR), time‐below‐range (TBR), daily glucose levels, total daily insulin dose and ketone body concentration.</p></section><section id="edm270096-sec-0003"><h3 class="pmc_sec_title">Results</h3>
<p>The BBT + E group exhibited a significantly higher TIR from day 2, which exceeded 70% by day 5, with reduced TAR and insulin requirements. Blood glucose levels declined more rapidly in the BBT + E group, accompanied by a modest ketone elevation without severe ketoacidosis. The TBR increased marginally on day 7, primarily nocturnally; but no symptomatic hypoglycaemia occurred.</p></section><section id="edm270096-sec-0004"><h3 class="pmc_sec_title">Conclusion</h3>
<p>The addition of SGLT2 inhibitors to BBT significantly improved early glycaemic control and reduced insulin requirements without severe ketone elevation in hospitalised T2DM patients. Routine monitoring of ketone levels and careful insulin titration are critical to ensure safety.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> glucotoxicity, hyperglycemia, intensive insulin therapy, SGL2 inhibitor</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p>This study compared the efficacy of intensive insulin therapy with empagliflozin (BBT + E) versus intensive insulin therapy alone (BBT) in hospitalised patients with type 2 diabetes admitted for hyperglycemia. The BBT + E group achieved an earlier improvement in time‐in‐range (TIR) compared to the BBT group. Although a mild increase in ketone bodies was observed, it remained within clinically acceptable levels.</p>
<section class="bt xbox font-sm" id="edm270096-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f7/12364101/b1074e6578f1/EDM2-8-e70096-g001.jpg" loading="lazy" id="jats-graphic-1" height="178" width="461" alt="graphic file with name EDM2-8-e70096-g001.jpg"></p></section></section><section id="edm270096-sec-0005"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Hyperglycemia can become exacerbated by the worsening of existing hypoinsulinemia and peripheral insulin resistance, thereby creating a vicious cycle known as glucotoxicity [<a href="#edm270096-bib-0001" class="usa-link" aria-describedby="edm270096-bib-0001">1</a>]. To address this issue, short‐term intensive insulin therapy (SIIT) has historically been used in patients with type 2 diabetes mellitus (T2DM) experiencing severe hyperglycemia [<a href="#edm270096-bib-0002" class="usa-link" aria-describedby="edm270096-bib-0002">2</a>, <a href="#edm270096-bib-0003" class="usa-link" aria-describedby="edm270096-bib-0003">3</a>, <a href="#edm270096-bib-0004" class="usa-link" aria-describedby="edm270096-bib-0004">4</a>, <a href="#edm270096-bib-0005" class="usa-link" aria-describedby="edm270096-bib-0005">5</a>]. This approach aims to achieve early glycemic control, mitigate glucotoxicity, restore beta‐cell function and improve insulin sensitivity.</p>
<p>Although conventional oral antidiabetic agents often target insulin secretion and sensitivity, their efficacy in mitigating glucotoxicity is limited. Even incretin‐based therapies, which can enhance insulin secretion, have shown diminished effectiveness due to the decreased expression of incretin receptors under conditions of glucotoxicity [<a href="#edm270096-bib-0006" class="usa-link" aria-describedby="edm270096-bib-0006">6</a>, <a href="#edm270096-bib-0007" class="usa-link" aria-describedby="edm270096-bib-0007">7</a>]. Thus, the ability of incretin‐related drugs to reverse glucotoxicity remains unclear.</p>
<p>In contrast, relatively novel sodium‐glucose co‐transporter 2 (SGLT2) inhibitors lower blood glucose levels through a unique mechanism of action by inhibiting SGLT2 activity in the proximal renal tubules, thereby promoting urinary glucose excretion independent of insulin activity. Clinically, SGLT2 inhibitors have demonstrated the potential to rapidly improve hyperglycemia and reduce the required insulin dose, particularly in patients with treatment‐resistant hyperglycemia [<a href="#edm270096-bib-0008" class="usa-link" aria-describedby="edm270096-bib-0008">8</a>]. However, increased fatty acid metabolism and ketone body synthesis induced by SGLT2 inhibitors raise concerns about the risk of ketosis and ketoacidosis (DKA) [<a href="#edm270096-bib-0009" class="usa-link" aria-describedby="edm270096-bib-0009">9</a>, <a href="#edm270096-bib-0010" class="usa-link" aria-describedby="edm270096-bib-0010">10</a>, <a href="#edm270096-bib-0011" class="usa-link" aria-describedby="edm270096-bib-0011">11</a>, <a href="#edm270096-bib-0012" class="usa-link" aria-describedby="edm270096-bib-0012">12</a>], particularly in patients with compromised beta‐cell function and inadequate insulin secretion.</p>
<p>Therefore, this study aimed to evaluate the efficacy and safety of combining SGLT2 inhibitors with conventional intensive insulin therapy in hospitalised patients with T2DM who presented with severe hyperglycaemia.</p></section><section id="edm270096-sec-0006"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<section id="edm270096-sec-0007"><h3 class="pmc_sec_title">2.1. Study Design and Participants</h3>
<p>This was a prospective, randomised, open‐label, single‐centre trial. The participants included patients with T2DM who were hospitalised to general wards from the outpatient setting to alleviate glucotoxicity and improve BG control, with no prior history of SGLT2 inhibitor use. Eligible participants were aged 20 years or older, with a BMI of at least 18 kg/m<sup>2</sup>. Inclusion criteria varied based on prior treatment: for untreated patients or those on diet therapy only, an HbA1c ≥ 10%; for those on oral antidiabetic drugs or once‐daily insulin injections, an HbA1c ≥ 8.0% was required. Exclusion criteria included type 1 diabetes, multiple daily injection therapy, pregnancy, weekly use of DPP‐4 inhibitors or glucagon‐like peptide 1 (GLP‐1) receptor agonists or dual GLP‐1 and glucose‐dependent insulinotropic peptide receptor agonists, a history of DKA or hyperglycaemic coma, prednisone ≥ 10 mg/day, cancer, ICU admission, severe infections, advanced retinopathy, eGFR &lt; 30 mL/min/1.73 m<sup>2</sup>, liver cirrhosis (Child‐Pugh B or higher), history of gastrointestinal operation or planned surgery during the study period. To exclude infections and stress‐related hyperglycaemia, all participants underwent chest radiography, general biochemical tests including C‐reactive protein and a complete blood count, and abdominal computed tomography upon hospital admission.</p>
<p>The study protocol was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000053224) and approved by the Ethics Committee of Ichinomiya Nishi Hospital. All participants provided informed consent.</p></section><section id="edm270096-sec-0008"><h3 class="pmc_sec_title">2.2. Procedures</h3>
<p>Baseline blood samples, including blood ketone bodies, were collected within one week prior to hospital admission to screen for ketosis, DKA, anti‐GAD antibodies and concomitant infections. After admission, all oral antidiabetic medications were discontinued. Participants were stratified into four groups based on the presence or absence of insulin injection use and HbA1c levels (&gt; 10% or 8%–10%). Randomisation was conducted using block randomisation with a block size of four within either the intensive insulin therapy alone group (BBT group) or the intensive insulin therapy combined with empagliflozin 10 mg/day (BBT + E group). The study period spanned from the day of admission (day 0) until day 7 thereafter. On day 0, all patients were equipped with the FreeStyle Libre Pro (Abbott Japan Diabetes Care Inc., Tokyo, Japan). Basal bolus therapy (BBT) was initiated in both groups from day 0, while the BBT + E group began empagliflozin administration on day 1. During the treatment period, flash glucose monitoring (FGM) was conducted continuously and BG was measured before meals and at bedtime. Urine ketone tests were performed every morning, and blood ketone levels were measured on days 1, 3 and 7 before breakfast, using the same POC testing device as for BG measurements. Both blood glucose and blood ketone levels were measured using point‐of‐care (POC) metres (Niprostat Strip XP3, Nova Biomedical, Waltham, MA, USA). Meals were standardised with total daily calories calculated as ideal body weight (height × height × 22) × 30 kcal. Macronutrient composition was set at 60% carbohydrates, 18% protein and 22% fat [<a href="#edm270096-bib-0013" class="usa-link" aria-describedby="edm270096-bib-0013">13</a>]. Regarding insulin administration, we initiated treatment with a low dose and set a relatively strict target fasting blood glucose level of 95–120 mg/dL, based on previous studies on glycaemic control in non‐ICU hospitalised patients with type 2 diabetes [<a href="#edm270096-bib-0014" class="usa-link" aria-describedby="edm270096-bib-0014">14</a>, <a href="#edm270096-bib-0015" class="usa-link" aria-describedby="edm270096-bib-0015">15</a>, <a href="#edm270096-bib-0016" class="usa-link" aria-describedby="edm270096-bib-0016">16</a>, <a href="#edm270096-bib-0017" class="usa-link" aria-describedby="edm270096-bib-0017">17</a>]. Basal insulin (glargine U‐300) was initiated at a dose of 0.15 U/kg/day (maximum 10 units/day) for patients under 70 years old and 0.10 U/kg/day (minimum 4 units/day, maximum 8 units/day) for those aged 70 years or older. Dose adjustments were made daily based on fasting blood glucose (FBG) levels: no change for 95–120 mg/dL, a 10% increase for 121–140 mg/dL and a 20% increase for ≥ 141 mg/dL. Dose reductions of 10%, 20% or 30%–40% were applied for FBG levels of 70–94 mg/dL, 40–70 mg/dL or &lt; 40 mg/dL, respectively. Bolus insulin (Lispro), divided into three equal doses of basal insulin, was administered before each meal. Sliding scale insulin was not used in this study. Hypoglycaemia was defined as the presence of hypoglycaemia or a BG level &lt; 70 mg/dL. For hypoglycaemic episodes, the patients received 10 g of oral glucose until resolution.</p>
<p>Treatment failure was defined as severe hypoglycemia (BG &lt; 40 mg/dL) occurring twice or more, a pre‐meal BG level &gt; 400 mg/dL, ketosis (defined as urinary ketone level of ≥ 3 + or β‐OHB ≥ 1.0 mmol/L) or DKA (defined as β‐OHB level ≥ 3.0 mmol/L). Severe hypoglycemia was managed with intravenous glucose supplementation, whereas hyperglycemia, ketosis and DKA were treated with intensive continuous intravenous insulin therapy.</p></section><section id="edm270096-sec-0009"><h3 class="pmc_sec_title">2.3. Outcomes</h3>
<p>The primary outcome was the time‐in‐range (TIR; 70–180 mg/dL) measured daily using FGM. Secondary outcomes included time‐above‐range (TAR; 181–250 mg/dL), time‐below‐range (TBR; level 1 &lt; 70 mg/dL, level 2 &lt; 54 mg/dL), pre‐meal and bedtime BG levels measured by POC metres, β‐hydroxybutyrate (β‐OHB) concentrations by POC metres, urine ketone tests and total daily insulin dose (TDD).</p></section><section id="edm270096-sec-0010"><h3 class="pmc_sec_title">2.4. Analysis</h3>
<p>This exploratory pilot study was designed with a significance level of 5% and a statistical power of 80%, considering feasibility constraints and the limited number of eligible cases. The sample size calculation was based on the results of a previous study, assuming a mean difference of 27 mg/dL in blood glucose level changes between the two groups and a standard deviation of 27 mg/dL [<a href="#edm270096-bib-0018" class="usa-link" aria-describedby="edm270096-bib-0018">18</a>]. Accordingly, a total of 32 participants (16 per group) were required, and the target sample size was set at 36 participants to account for potential dropouts. Data analysis was performed using EZR software (Saitama Medical Center, Jichi Medical University, Saitama, Japan) [<a href="#edm270096-bib-0019" class="usa-link" aria-describedby="edm270096-bib-0019">19</a>]. All available data during hospitalisation were included in the analysis. Continuous variables following a normal distribution were reported as mean ± standard deviation and analysed utilising the t‐test, while for those not following a normal distribution, data were expressed as medians and interquartile ranges and analysed using the rank‐sum test. Non‐continuous variables are presented as absolute numbers and percentages. Urinary ketone test results were transformed to an ordinal scale and subsequently analysed using the Mann–Whitney U test. Other categorical variables were analysed using the chi‐square test.</p></section></section><section id="edm270096-sec-0011"><h2 class="pmc_sec_title">3. Results</h2>
<p>A total of 37 eligible T2DM patients were admitted to our hospital between 26 December2023, and 1 August 2024. The patients were recruited and randomly allocated into stratified groups. Two patients were excluded from the analysis, one due to treatment interruption immediately after admission and the other due to protocol deviation. Consequently, data from 35 patients were analysed: 17 in the BBT group and 18 in the BBT + E group (Figure <a href="#edm270096-fig-0001" class="usa-link">1</a>). The baseline characteristics of the patients are summarised in Table <a href="#edm270096-tbl-0001" class="usa-link">1</a>. No significant differences were observed between the two groups in terms of age, sex, BMI, medical history, HbA1c, BG, C‐peptide reactivity, β‐OHB by a central laboratory reference method, estimated glomerular filtration rate (eGFR), microvascular and macrovascular complications, previous treatments, or diabetes medications.</p>
<figure class="fig xbox font-sm" id="edm270096-fig-0001"><h3 class="obj_head">FIGURE 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f7/12364101/4f0370e15470/EDM2-8-e70096-g002.jpg" loading="lazy" id="jats-graphic-3" height="332" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/edm270096-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Patient disposition flowchart. BBT, basal bolus therapy; BBT + E, BBT plus empagliflozin.</p></figcaption></figure><section class="tw xbox font-sm" id="edm270096-tbl-0001"><h3 class="obj_head">TABLE 1.</h3>
<div class="caption p"><p>Clinical characteristics of study patients.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">BBT</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">BBT + E</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">P‐value</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Number of patients</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">18</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age</td>
<td align="center" valign="top" rowspan="1" colspan="1">65.6 ± 16.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">63.8 ± 15.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.748</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Male, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (65)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (39)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.181</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">27.4 ± 5.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.5 ± 4.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.111</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Duration of diabetes, years</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.8 ± 13.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.9 ± 9.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.487</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HbA1c, %</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.1 ± 2.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.2 ± 1.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.975</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Glu, mg/dl</td>
<td align="center" valign="top" rowspan="1" colspan="1">251.7 ± 69.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">269.8 ± 101.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.543</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">C‐peptide reactivity, ng/dl</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 ± 1.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 ± 1.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.901</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">β‐OHB, mmol/L</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.05 [0.04, 0.17]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.09 [0.02, 0.20]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.759</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">eGFR, mL/min/1.73m<sup>2</sup>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">69.5 ± 22.35</td>
<td align="center" valign="top" rowspan="1" colspan="1">69.3 ± 27.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.986</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Microvascular complications</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Diabetic nephropathy (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9 (53)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (39)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.505</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Diabetic retinopathy (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (18)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (33)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.443</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Diabetic neuropathy (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9 (53)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (44)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.740</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">≥ 2 microvascular complication (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (47)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (39)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.738</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Macrovascular disease</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Coronary artery disease (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cerebrovascular disease (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Peripheral arterial disease (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (5.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">≥ 1 macrovascular condition (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (24)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (22)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Previous treatment</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Diet alone, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (36)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (44)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.733</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Oral agents only, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (47)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (39)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.738</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Daily GLP‐1RA + oral agents, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (5.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Insulin+oral agents, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (11.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (11.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Insulin+Daily GLP‐RA + oral agents, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (5.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.486</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Drug agents</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">DPP4 inhibitor, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (59)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (44)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.505</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Biguanide, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (47)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (22)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.164</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sulfonylurea, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (18)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.658</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Alpha‐glucosidase inhibitor, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Thiazolidine, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.229</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Basal insulin, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (18)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.658</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Daily GLP‐1RA, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/edm270096-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="edm270096-note-0002"><p>Abbreviations: β‐OHB, β‐hydroxybutyrate; eGFR, estimated glomerular filtration rate. DPP‐4, dipeptidyl peptidase‐4; GLP‐1RA, glucagon‐like peptide 1 receptor agonists.</p></div></div></section><p>Table <a href="#edm270096-tbl-0002" class="usa-link">2</a> summarises the study outcomes of FGM and ketone body. The TIR was significantly higher in the BBT + E group starting from day 2 of treatment and remained elevated until day 6. Conversely, the TAR was significantly lower in the BBT + E group from day 2 and persisted until day 7. TBR at blood glucose levels &lt; 70 mg/dL was significantly higher in the BBT + E group on day 7, although TBR at levels &lt; 54 mg/dL was rare in both groups (Figure <a href="#edm270096-fig-0002" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="edm270096-tbl-0002"><h3 class="obj_head">TABLE 2.</h3>
<div class="caption p"><p>Study outcomes of FGM and ketone body.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" colspan="3" valign="bottom" rowspan="1">Day 0</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">Day 1</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">Day 2</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">Day 3</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">BBT (<em>n</em> = 17)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">BBT + E (<em>n</em> = 18)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>P</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">BBT (<em>n</em> = 17)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">BBT + E (<em>n</em> = 18)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>P</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">BBT (<em>n</em> = 17)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">BBT + E (<em>n</em> = 18)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>P</em>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">BBT (<em>n</em> = 17)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">BBT + E (<em>n</em> = 18)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>P</em>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TAR: &gt; 180, %</td>
<td align="center" valign="top" rowspan="1" colspan="1">74.2 ± 35.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">68.7 ± 27.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.634</td>
<td align="center" valign="top" rowspan="1" colspan="1">63.9 ± 27.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">48.2 ± 29.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.132</td>
<td align="center" valign="top" rowspan="1" colspan="1">59.9 ± 28.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">36.9 ± 32.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.044*</td>
<td align="center" valign="top" rowspan="1" colspan="1">57.6 ± 30.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.8 ± 22.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.012*</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TIR: 70–180, %</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.4 ± 29.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.3 ± 27.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.394</td>
<td align="center" valign="top" rowspan="1" colspan="1">34.3 ± 27.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">51.7 ± 28.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.096</td>
<td align="center" valign="top" rowspan="1" colspan="1">39.8 ± 28.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">62.2 ± 31.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.047*</td>
<td align="center" valign="top" rowspan="1" colspan="1">42.2 ± 29.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">65.6 ± 20.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.017*</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TBR level 1: &lt; 70, %</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.2 ± 12.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.341</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.8 ± 6.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1 ± 0.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.326</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.3 ± 1.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.8 ± 2.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.487</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1 ± 0.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.6 ± 7.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.210</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TBR level 2: &lt; 54, %</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.3 ± 9.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.341</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.3 ± 4.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.289</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2 ± 0.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.310</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">β‐OHB, mmol/L</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1 [0.1–0.2]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2 [0.1–0.3]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.262</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">0.2 [0.1–0.3]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.5 [0.2–0.6]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.021*</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Urine ketone ‐, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (94)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (100)</td>
<td align="center" rowspan="4" valign="top" colspan="1">0.316</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (100)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (94)</td>
<td align="center" rowspan="4" valign="top" colspan="1">0.377</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (94)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (82)</td>
<td align="center" rowspan="4" valign="top" colspan="1">0.374</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (88)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (88)</td>
<td align="center" rowspan="4" valign="top" colspan="1">1.000</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">+, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">2+, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (12)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">3+, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TDD, U/day</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.6 ± 2.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.4 ± 3.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.890</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.6 ± 4.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">15.9 ± 4.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.614</td>
<td align="center" valign="top" rowspan="1" colspan="1">19.1 ± 5.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.0 ± 5.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.538</td>
<td align="center" valign="top" rowspan="1" colspan="1">21.6 ± 6.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">19.6 ± 5.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.330</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" colspan="3" valign="top" rowspan="1">Day 4</td>
<td align="center" colspan="3" valign="top" rowspan="1">Day 5</td>
<td align="center" colspan="3" valign="top" rowspan="1">Day 6</td>
<td align="center" colspan="3" valign="top" rowspan="1">Day 7</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">BBT (<em>n</em> = 17)</td>
<td align="center" valign="top" rowspan="1" colspan="1">BBT + E (<em>n</em> = 18)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>P</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">BBT (<em>n</em> = 17)</td>
<td align="center" valign="top" rowspan="1" colspan="1">BBT + E (<em>n</em> = 18)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>P</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">BBT (<em>n</em> = 17)</td>
<td align="center" valign="top" rowspan="1" colspan="1">BBT + E (<em>n</em> = 17)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>P</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">BBT (<em>n</em> = 16)</td>
<td align="center" valign="top" rowspan="1" colspan="1">BBT + E (<em>n</em> = 16)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>P</em>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TAR: &gt; 180, %</td>
<td align="center" valign="top" rowspan="1" colspan="1">55.8 ± 28.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">28.5 ± 15.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.024*</td>
<td align="center" valign="top" rowspan="1" colspan="1">49.3 ± 24.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.1 ± 18.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.023*</td>
<td align="center" valign="top" rowspan="1" colspan="1">43.6 ± 22.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.6 ± 20.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.007*</td>
<td align="center" valign="top" rowspan="1" colspan="1">35.8 ± 16.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.1 ± 18.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.023*</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TIR: 70–180, %</td>
<td align="center" valign="top" rowspan="1" colspan="1">42.6 ± 25.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">69.3 ± 14.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.013*</td>
<td align="center" valign="top" rowspan="1" colspan="1">49.6 ± 23.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">75.5 ± 18.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.021*</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.6 ± 25.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">77.4 ± 20.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.012*</td>
<td align="center" valign="top" rowspan="1" colspan="1">64.2 ± 16.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">74.9 ± 17.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.101</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TBR level 1: &lt; 70, %</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.4 ± 4.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.8 ± 4.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.827</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.8 ± 3.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.3 ± 5.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.5 ± 5.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.7 ± 4.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.913</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.3 ± 8.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.046</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TBR level 2: &lt; 54, %</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">β‐OHB, mmol/L</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">0.1 [0.1–0.3]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.3 [0.2–0.4]</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.049*</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Urine ketone ‐, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (88)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (88)</td>
<td align="center" rowspan="4" valign="top" colspan="1">0.975</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (94)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (88)</td>
<td align="center" rowspan="4" valign="top" colspan="1">0.588</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (100)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12 (75)</td>
<td align="center" rowspan="4" valign="top" colspan="1">0.039*</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (100)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13 (87)</td>
<td align="center" rowspan="4" valign="top" colspan="1">0.150</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">+, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (13)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (19)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (13)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">2+, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">3+, <em>n</em> (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TDD, U/day</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.5 ± 7.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.4 ± 6.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.188</td>
<td align="center" valign="top" rowspan="1" colspan="1">25.3 ± 8.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.7 ± 6.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.084</td>
<td align="center" valign="top" rowspan="1" colspan="1">28.6 ± 12.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.2 ± 7.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.089</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.8 ± 0.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.4 ± 0.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.029*</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/edm270096-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="edm270096-note-0003"><p>Abbreviations: TAR, time‐above‐range; TIR, time‐in‐range; TBR, time‐below‐range. β‐OHB, β‐hydroxybutyrate; TDD, total daily insulin dose.</p></div></div></section><figure class="fig xbox font-sm" id="edm270096-fig-0002"><h3 class="obj_head">FIGURE 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f7/12364101/d4b8f812f589/EDM2-8-e70096-g003.jpg" loading="lazy" id="jats-graphic-5" height="273" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/edm270096-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Daily FGM metrics. FGM, flash glucose monitoring; BBT, basal bolus therapy; BBT + E, BBT plus empagliflozin; TAR, time‐above‐range; TIR, time‐in‐range; TBR, time‐below‐range.</p></figcaption></figure><p>Fasting β‐OHB levels by POC metres were significantly higher in the BBT + E group on days 3 and 7, with the percentage of urinary ketones showing a slight increase on day 6. The TDD of insulin tended to be lower in the BBT + E group from day 3 onwards and reached statistical significance on day 7. Moreover, BG levels measured using POC glucometers demonstrated a significant reduction in the mean daily BG levels in the BBT + E group starting from day 3. This reduction was also evident in mean pre‐meal BG levels (Figure <a href="#edm270096-fig-0003" class="usa-link">3</a>).</p>
<figure class="fig xbox font-sm" id="edm270096-fig-0003"><h3 class="obj_head">FIGURE 3.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f7/12364101/f71e586e127f/EDM2-8-e70096-g004.jpg" loading="lazy" id="jats-graphic-7" height="233" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/edm270096-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Differences in glycemic control in hospitalised patients with type 2 diabetes mellitus treated with BBT and BBT + E. (A) Mean blood glucose concentrations before and after each meal. (B) Mean daily blood glucose levels during the study. BBT, basal bolus therapy; BBT + E, BBT plus empagliflozin.</p></figcaption></figure><p>No symptoms of urinary tract or genital infections were observed in either group. Severe hypoglycaemia with BG levels below 40 mg/dL was not observed in either group. Two patients in the BBT group experienced one episode each of hypoglycaemia requiring glucose administration, and one such episode occurred in a single patient in the BBT + E group. All episodes were promptly resolved with glucose administration. Furthermore, no cases of DKA or preprandial BG levels exceeding 400 mg/dL were observed in either group, and no participants discontinued the study.</p></section><section id="edm270096-sec-0012"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>This study demonstrated that in the management of blood glucose in hospitalised T2DM patients with hyperglycemia, combination therapy with BBT and empagliflozin achieved considerably higher TIR and lower insulin requirements at an earlier stage than conventional BBT alone.</p>
<p>The recommended TIR target for T2DM outpatients using FGM is 70%. However, no specific TIR target has been established for T2DM inpatients. Previous studies on SIIT aimed at FBG &lt; 110 mg/dL and postprandial BG &lt; 144 mg/dL to resolve glucotoxicity [<a href="#edm270096-bib-0003" class="usa-link" aria-describedby="edm270096-bib-0003">3</a>, <a href="#edm270096-bib-0020" class="usa-link" aria-describedby="edm270096-bib-0020">20</a>, <a href="#edm270096-bib-0021" class="usa-link" aria-describedby="edm270096-bib-0021">21</a>]. Recent literature indicates that implementing an 8‐point capillary BG measurement during SIIT and utilising stricter target ranges for BG levels—70–108 mg/dL for preprandial BG and 70–140 mg/dL for postprandial BG 2 h after meals—demonstrated beneficial effects in restoring beta‐cell function and insulin sensitivity when the target achievement rate was 65% or higher [<a href="#edm270096-bib-0022" class="usa-link" aria-describedby="edm270096-bib-0022">22</a>]. Furthermore, regarding the duration until the resolution of glucotoxicity, when clinical resolution is defined as the point at which TDD begins to decrease, SIIT using subcutaneous injections has been reported to require an average of 8.9 ± 4.3 days [<a href="#edm270096-bib-0023" class="usa-link" aria-describedby="edm270096-bib-0023">23</a>].</p>
<p>In this study, the BBT + E group demonstrated a significant increase in TIR by day 2, exceeding 70% on day 5, and this level was maintained thereafter. The TDD in the BBT + E group showed a slight increase after day 4 and remained lower than that in the BBT group. The rapid onset of the hypoglycemic effects of SGLT2 inhibitors [<a href="#edm270096-bib-0024" class="usa-link" aria-describedby="edm270096-bib-0024">24</a>] likely contributes to the early increase in TIR and resolution of glucotoxicity. In contrast, the TIR in the BBT group increased more gradually, reaching 65% by day 7, with the TDD continuing to increase throughout the study period, indicating incomplete glucotoxicity resolution.</p>
<p>The insulin dose progressively increases following the initiation of SIIT, and after glucotoxicity resolves, the insulin dose turns to decrease [<a href="#edm270096-bib-0023" class="usa-link" aria-describedby="edm270096-bib-0023">23</a>]. However, failure to appropriately reduce the insulin dosage leads to an increased risk of hypoglycemia [<a href="#edm270096-bib-0024" class="usa-link" aria-describedby="edm270096-bib-0024">24</a>]. The BBT + E group demonstrated a narrower range of insulin dose adjustments without dose reduction, which potentially minimised the risk of hypoglycemia. Previous studies have shown that combining insulin therapy with SGLT2 inhibitors in outpatients does not increase the risk [<a href="#edm270096-bib-0025" class="usa-link" aria-describedby="edm270096-bib-0025">25</a>, <a href="#edm270096-bib-0026" class="usa-link" aria-describedby="edm270096-bib-0026">26</a>] and may reduce nocturnal hypoglycemia [<a href="#edm270096-bib-0027" class="usa-link" aria-describedby="edm270096-bib-0027">27</a>]. In the current study, the increased TIR was attributed to reductions in TAR without increases in TBR until day 6. However, on day 7, the BBT + E group exhibited a significant increase in TBR level 1, which was mainly observed during the nocturnal period. The low frequency of hypoglycemia observed in the BBT group may be attributed to its inability to resolve glucotoxicity. The FGM readings predominantly fell within the 60–69 mg/dL range, and no hypoglycemic symptoms were reported. Therefore, the possibility of pseudohypoglycemia cannot be excluded because of the significant margin of error associated with FGM measurements in the hypoglycemic range [<a href="#edm270096-bib-0028" class="usa-link" aria-describedby="edm270096-bib-0028">28</a>]. Additionally, the fact that SGLT2 inhibitors do not exert effects in the hypoglycemic range suggests that insulin administration may play a primary role in the occurrence of hypoglycemia. Further investigations are warranted to establish appropriate protocols for insulin administration in patients receiving SGLT2 inhibitors in the BBT group.</p>
<p>Regarding ketone dynamics, this study observed significant increases in blood and urine ketones with SGLT2 inhibitor treatment, which is consistent with previous reports. Elevated ketone levels are frequently observed during treatment with SGLT2 inhibitors, with fasting ketone concentrations reportedly increasing by approximately twofold [<a href="#edm270096-bib-0029" class="usa-link" aria-describedby="edm270096-bib-0029">29</a>]. In a previous study, administration of empagliflozin at a dosage of 25 mg/day for 28 days in T2DM patients who exhibited relatively well‐controlled glycemia resulted in β‐OHB levels ranging from 0.24 mmol/L to 0.56 mmol/L. [<a href="#edm270096-bib-0030" class="usa-link" aria-describedby="edm270096-bib-0030">30</a>] These findings are consistent with our results and reflect an increase within a clinically safe range. These small increases in ketone bodies may exert anti‐inflammatory, antioxidant and cardiorenal protective effects, potentially offering additional benefits [<a href="#edm270096-bib-0029" class="usa-link" aria-describedby="edm270096-bib-0029">29</a>]. However, DKA associated with SGLT2 inhibitors can occasionally present as a severe condition [<a href="#edm270096-bib-0031" class="usa-link" aria-describedby="edm270096-bib-0031">31</a>] that develops shortly after initiation of treatment [<a href="#edm270096-bib-0032" class="usa-link" aria-describedby="edm270096-bib-0032">32</a>]. SGLT2 inhibitor‐induced DKA often manifests as normoglycemic acidosis, which may not be promptly detected if blood glucose levels are monitored alone. Therefore, routine monitoring of urinary and blood ketone levels is essential for early detection and appropriate management [<a href="#edm270096-bib-0033" class="usa-link" aria-describedby="edm270096-bib-0033">33</a>]. Patients with type 1 diabetes mellitus, ketosis, DKA or acute complications were excluded, and insulin therapy was initiated on day 0, the day before SGLT2 inhibitor administration. This protocol may enhance therapeutic safety.</p>
<p>The efficacy of combining insulin therapy with SGLT2 inhibitors for glycemic management in outpatients has been previously reported [<a href="#edm270096-bib-0034" class="usa-link" aria-describedby="edm270096-bib-0034">34</a>, <a href="#edm270096-bib-0035" class="usa-link" aria-describedby="edm270096-bib-0035">35</a>]. The results of this study suggest that the addition of SGLT2 inhibitors to BBT may also offer a relatively safe and effective approach to achieving target blood glucose levels in hospitalised patients with type 2 diabetes mellitus and hyperglycaemia. This strategy may contribute to shortening the overall treatment duration and reducing the length of hospital stay. To examine this possibility, we retrospectively analysed hospitalisation duration; however, no significant differences were observed between the two groups (BBT group: 11.5 ± 2.0 days; BBT + E group: 12.6 ± 2.5 days; <em>p</em> = 0.410). We believe this outcome was strongly influenced by Japan's hospitalisation system, which is governed by the Diagnosis Procedure Combination (DPC) framework, whereby hospitalisation length is largely determined by the principal diagnosis. Under this system, variability in hospitalisation duration among patients tends to be minimal. Therefore, we excluded hospitalisation duration from the predefined outcome measures. Additionally, treatment procedures leading up to discharge were not standardised, which may have further contributed to this result. In settings where post–glucotoxicity treatment protocols are unified and discharge timing is determined based on clinical goals such as improvement in glycemic control, it is conceivable that the length of hospital stay may be shortened in the BBT + SGLT2 group.</p></section><section id="edm270096-sec-0013"><h2 class="pmc_sec_title">5. Study Limitations</h2>
<p>This study has several important limitations that should be acknowledged.</p>
<p>First, this was a single‐centre pilot study with a small number of participants, limiting the statistical power and generalisability of the results. Although all participants were deemed to require inpatient treatment, hospitalisation criteria may vary across institutions, and thus caution should be exercised when applying these findings to different healthcare systems. Additionally, all participants were Japanese, lacking racial and ethnic diversity. Future multicentre studies involving larger and more diverse populations are warranted.</p>
<p>Second, the observation period was limited to 7 days, which did not allow for evaluation of long‐term glycemic durability, β‐cell preservation or clinical outcomes. The short duration also did not allow for assessment of hospitalisation length or discharge‐related outcomes. Although a slight increase in ketone bodies was observed, its long‐term clinical relevance remains uncertain. While no cases of DKA occurred during the study, the risk cannot be completely ruled out; careful monitoring remains necessary.</p>
<p>Third, the open‐label design may have introduced observer bias, particularly regarding insulin dose adjustment and adverse event reporting. Although glucose and ketone levels were measured objectively, it is possible that clinicians were aware of treatment allocation during decision‐making.</p>
<p>Fourth, although no cases of DKA, ketosis or marked hyperglycemia were observed in this study, high‐risk populations—such as patients with a history of DKA, advanced renal dysfunction, or serious comorbidities—were excluded. Therefore, the findings may not be directly applicable to these vulnerable groups. Moreover, due to limited retrospective information, we could not fully assess participants' prior medication history, which may have influenced treatment responses. This study also did not systematically assess the adverse events associated with SGLT2 inhibitors, such as urinary tract or genital infections [<a href="#edm270096-bib-0036" class="usa-link" aria-describedby="edm270096-bib-0036">36</a>, <a href="#edm270096-bib-0037" class="usa-link" aria-describedby="edm270096-bib-0037">37</a>], nor did it evaluate risks associated with long‐term use, leaving the safety profile incomplete.</p>
<p>Fifth, although the overall frequency of hypoglycemia was low in both groups, mild and asymptomatic nocturnal hypoglycemia was more frequently observed in the BBT + E group. Neither finger‐stick confirmation nor individualised insulin titration was performed, suggesting room for improvement in future protocol design.</p>
<p>Finally, future studies should assess the effects on pancreatic β‐cell function using indices such as C‐peptide levels, as well as evaluate patient‐reported outcomes including treatment satisfaction. Comparative trials with other antidiabetic agents, such as DPP‐4 inhibitors, as well as with conventional SIIT, could help clarify the therapeutic positioning and potential β‐cell protective effects of this approach.</p></section><section id="edm270096-sec-0014"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Design: Nobutoshi Fushimi. Conduct/data collection: Nobutoshi Fushimi, Hiroki Hachiya, Tatsuya Iwasaka. Analysis: Nobutoshi Fushimi, Machi Nagao, Tomoki Masamura, Kohei Higashi. Writing manuscript: Nobutoshi Fushimi, Akihiro Mori.</p></section><section id="edm270096-sec-0016"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>Approval of the research protocol: The study protocol was approved by the Ethics Committee of Ichinomiya Nishi Hospital. Approval date of Registry and the Registration No. of the study/trial: The study protocol was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000053224).</p></section><section id="edm270096-sec-1017"><h2 class="pmc_sec_title">Consent</h2>
<p>All participants provided informed consent.</p></section><section id="edm270096-sec-0017"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="edm270096-sec-0015" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We would like to express our sincere gratitude to the nursing staff of the Department of Endocrinology and Diabetes for their invaluable assistance in collecting the specimen data used in this study. We also wish to extend our appreciation to our fellow physicians for their constructive feedback during the manuscript preparation process.</p></section><section id="notes1"><p>

Fushimi N., Hachiya H., Iwasaka T., et al., “Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study,” Endocrinology, Diabetes &amp; Metabolism
8, no. 5 (2025): e70096, 10.1002/edm2.70096.
</p>
<section id="edm270096-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="edm270096-note-0001"><p>
<strong>Funding:</strong> This research received no external funding.</p></div></div></section></section><section id="edm270096-sec-0019"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Due to the nature of this research, the study participants did not agree for their data to be shared publicly; as such, supporting data is not available.</p></section><section id="edm270096-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="edm270096-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="edm270096-bib-0001">
<span class="label">1.</span><cite>
Rossetti L., Giaccari A., and DeFronzo R. A., “Glucose Toxicity,” Diabetes Care
13, no. 6 (1990): 610–630.
</cite> [<a href="https://doi.org/10.2337/diacare.13.6.610" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2192847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Glucose%20Toxicity&amp;author=L.%20Rossetti&amp;author=A.%20Giaccari&amp;author=R.%20A.%20DeFronzo&amp;volume=13&amp;issue=6&amp;publication_year=1990&amp;pages=610-630&amp;pmid=2192847&amp;doi=10.2337/diacare.13.6.610&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0002">
<span class="label">2.</span><cite>
Chen H. S., Wu T. E., Jap T. S., Hsiao L. C., Lee S. H., and Lin H. D., “Beneficial Effects of Insulin on Glycemic Control and β‐Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short‐Term Intensive Insulin Therapy,” Diabetes Care
31, no. 10 (2008): 1927–1932.
</cite> [<a href="https://doi.org/10.2337/dc08-0075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2551629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18556343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Beneficial%20Effects%20of%20Insulin%20on%20Glycemic%20Control%20and%20%CE%B2%E2%80%90Cell%20Function%20in%20Newly%20Diagnosed%20Type%202%20Diabetes%20With%20Severe%20Hyperglycemia%20After%20Short%E2%80%90Term%20Intensive%20Insulin%20Therapy&amp;author=H.%20S.%20Chen&amp;author=T.%20E.%20Wu&amp;author=T.%20S.%20Jap&amp;author=L.%20C.%20Hsiao&amp;author=S.%20H.%20Lee&amp;volume=31&amp;issue=10&amp;publication_year=2008&amp;pages=1927-1932&amp;pmid=18556343&amp;doi=10.2337/dc08-0075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0003">
<span class="label">3.</span><cite>
Weng J., Li Y., Xu W., et al., “Effect of Intensive Insulin Therapy on β‐Cell Function and Glycaemic Control in Patients With Newly Diagnosed Type 2 Diabetes: A Multicentre Randomised Parallel‐Group Trial,” Lancet
371, no. 9626 (2008): 1753–1760.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(08)60762-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18502299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Effect%20of%20Intensive%20Insulin%20Therapy%20on%20%CE%B2%E2%80%90Cell%20Function%20and%20Glycaemic%20Control%20in%20Patients%20With%20Newly%20Diagnosed%20Type%202%20Diabetes:%20A%20Multicentre%20Randomised%20Parallel%E2%80%90Group%20Trial&amp;author=J.%20Weng&amp;author=Y.%20Li&amp;author=W.%20Xu&amp;volume=371&amp;issue=9626&amp;publication_year=2008&amp;pages=1753-1760&amp;pmid=18502299&amp;doi=10.1016/S0140-6736(08)60762-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0004">
<span class="label">4.</span><cite>
Retnakaran R., Yakubovich N., Qi Y., Opsteen C., and Zinman B., “The Response to Short‐Term Intensive Insulin Therapy in Type 2 Diabetes,” Diabetes, Obesity &amp; Metabolism
12, no. 1 (2010): 65–71.</cite> [<a href="https://doi.org/10.1111/j.1463-1326.2009.01129.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19740080/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes,%20Obesity%20&amp;%20Metabolism&amp;title=The%20Response%20to%20Short%E2%80%90Term%20Intensive%20Insulin%20Therapy%20in%20Type%202%20Diabetes&amp;author=R.%20Retnakaran&amp;author=N.%20Yakubovich&amp;author=Y.%20Qi&amp;author=C.%20Opsteen&amp;author=B.%20Zinman&amp;volume=12&amp;issue=1&amp;publication_year=2010&amp;pages=65-71&amp;pmid=19740080&amp;doi=10.1111/j.1463-1326.2009.01129.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0005">
<span class="label">5.</span><cite>
Kramer C. K., Zinman B., and Retnakaran R., “Short‐Term Intensive Insulin Therapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis,” Lancet Diabetes and Endocrinology
1, no. 1 (2013): 28–34.
</cite> [<a href="https://doi.org/10.1016/S2213-8587(13)70006-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24622264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Diabetes%20and%20Endocrinology&amp;title=Short%E2%80%90Term%20Intensive%20Insulin%20Therapy%20in%20Type%202%20Diabetes%20Mellitus:%20A%20Systematic%20Review%20and%20Meta%E2%80%90Analysis&amp;author=C.%20K.%20Kramer&amp;author=B.%20Zinman&amp;author=R.%20Retnakaran&amp;volume=1&amp;issue=1&amp;publication_year=2013&amp;pages=28-34&amp;pmid=24622264&amp;doi=10.1016/S2213-8587(13)70006-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0006">
<span class="label">6.</span><cite>
Kaneto H., Obata A., Shimoda M., et al., “Promising Diabetes Therapy Based on the Molecular Mechanism for Glucose Toxicity: Usefulness of SGLT2 Inhibitors as Well as Incretin‐Related Drugs,” Current Medicinal Chemistry
23, no. 27 (2016): 3044–3051.
</cite> [<a href="https://doi.org/10.2174/0929867323666160627102516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27356542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Medicinal%20Chemistry&amp;title=Promising%20Diabetes%20Therapy%20Based%20on%20the%20Molecular%20Mechanism%20for%20Glucose%20Toxicity:%20Usefulness%20of%20SGLT2%20Inhibitors%20as%20Well%20as%20Incretin%E2%80%90Related%20Drugs&amp;author=H.%20Kaneto&amp;author=A.%20Obata&amp;author=M.%20Shimoda&amp;volume=23&amp;issue=27&amp;publication_year=2016&amp;pages=3044-3051&amp;pmid=27356542&amp;doi=10.2174/0929867323666160627102516&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0007">
<span class="label">7.</span><cite>
Xu G., Kaneto H., Laybutt D. R., et al., “Downregulation of GLP‐1 and GIP Receptor Expression by Hyperglycemia: Possible Contribution to Impaired Incretin Effects in Diabetes,” Diabetes
56, no. 6 (2007): 1551–1558.
</cite> [<a href="https://doi.org/10.2337/db06-1033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17360984/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Downregulation%20of%20GLP%E2%80%901%20and%20GIP%20Receptor%20Expression%20by%20Hyperglycemia:%20Possible%20Contribution%20to%20Impaired%20Incretin%20Effects%20in%20Diabetes&amp;author=G.%20Xu&amp;author=H.%20Kaneto&amp;author=D.%20R.%20Laybutt&amp;volume=56&amp;issue=6&amp;publication_year=2007&amp;pages=1551-1558&amp;pmid=17360984&amp;doi=10.2337/db06-1033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0008">
<span class="label">8.</span><cite>
Abdul‐Ghani M. A., Norton L., and DeFronzo R. A., “Role of Sodium‐Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes,” Endocrine Reviews
32, no. 4 (2011): 515–531.
</cite> [<a href="https://doi.org/10.1210/er.2010-0029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21606218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrine%20Reviews&amp;title=Role%20of%20Sodium%E2%80%90Glucose%20Cotransporter%202%20(SGLT%202)%20Inhibitors%20in%20the%20Treatment%20of%20Type%202%20Diabetes&amp;author=M.%20A.%20Abdul%E2%80%90Ghani&amp;author=L.%20Norton&amp;author=R.%20A.%20DeFronzo&amp;volume=32&amp;issue=4&amp;publication_year=2011&amp;pages=515-531&amp;pmid=21606218&amp;doi=10.1210/er.2010-0029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0009">
<span class="label">9.</span><cite>
Qiu H., Novikov A., and Vallon V., “Ketosis and Diabetic Ketoacidosis in Response to SGLT2 Inhibitors: Basic Mechanisms and Therapeutic Perspectives,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
33, no. 5 (2017): e2886, 10.1002/dmrr.2886.</cite> [<a href="https://doi.org/10.1002/dmrr.2886" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28099783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes,%20Metabolic%20Syndrome%20and%20Obesity:%20Targets%20and%20Therapy&amp;title=Ketosis%20and%20Diabetic%20Ketoacidosis%20in%20Response%20to%20SGLT2%20Inhibitors:%20Basic%20Mechanisms%20and%20Therapeutic%20Perspectives&amp;author=H.%20Qiu&amp;author=A.%20Novikov&amp;author=V.%20Vallon&amp;volume=33&amp;issue=5&amp;publication_year=2017&amp;pages=e2886&amp;pmid=28099783&amp;doi=10.1002/dmrr.2886&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0010">
<span class="label">10.</span><cite>
Fleming N., Hamblin P. S., Story D., et al., “Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium‐Glucose Cotransporter 2 Inhibitors,” Journal of Clinical Endocrinology and Metabolism
105, no. 5 (2020): dgaa200.
</cite> [<a href="https://doi.org/10.1210/clinem/dgaa200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32302001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Endocrinology%20and%20Metabolism&amp;title=Evolving%20Evidence%20of%20Diabetic%20Ketoacidosis%20in%20Patients%20Taking%20Sodium%E2%80%90Glucose%20Cotransporter%202%20Inhibitors&amp;author=N.%20Fleming&amp;author=P.%20S.%20Hamblin&amp;author=D.%20Story&amp;volume=105&amp;issue=5&amp;publication_year=2020&amp;pages=dgaa200&amp;pmid=32302001&amp;doi=10.1210/clinem/dgaa200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0011">
<span class="label">11.</span><cite>
Colacci M., Fralick J., Odutayo A., and Fralick M., “Sodium‐Glucose Cotransporter‐2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta‐Analysis,” Canadian Journal of Diabetes
46, no. 1 (2022): 10–15.e2.
</cite> [<a href="https://doi.org/10.1016/j.jcjd.2021.04.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34116926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Canadian%20Journal%20of%20Diabetes&amp;title=Sodium%E2%80%90Glucose%20Cotransporter%E2%80%902%20Inhibitors%20and%20Risk%20of%20Diabetic%20Ketoacidosis%20Among%20Adults%20With%20Type%202%20Diabetes:%20A%20Systematic%20Review%20and%20Meta%E2%80%90Analysis&amp;author=M.%20Colacci&amp;author=J.%20Fralick&amp;author=A.%20Odutayo&amp;author=M.%20Fralick&amp;volume=46&amp;issue=1&amp;publication_year=2022&amp;pages=10-15.e2&amp;pmid=34116926&amp;doi=10.1016/j.jcjd.2021.04.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0012">
<span class="label">12.</span><cite>
Douros A., Lix L. M., Fralick M., et al., “Sodium–Glucose Cotransporter‐2 Inhibitors and the Risk for Diabetic Ketoacidosis: A Multicenter Cohort Study,” Annals of Internal Medicine
173, no. 6 (2020): 417–425.
</cite> [<a href="https://doi.org/10.7326/M20-0289" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32716707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Internal%20Medicine&amp;title=Sodium%E2%80%93Glucose%20Cotransporter%E2%80%902%20Inhibitors%20and%20the%20Risk%20for%20Diabetic%20Ketoacidosis:%20A%20Multicenter%20Cohort%20Study&amp;author=A.%20Douros&amp;author=L.%20M.%20Lix&amp;author=M.%20Fralick&amp;volume=173&amp;issue=6&amp;publication_year=2020&amp;pages=417-425&amp;pmid=32716707&amp;doi=10.7326/M20-0289&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0013">
<span class="label">13.</span><cite>
Yamauchi T., Kamiya H., Utsunomiya K., et al., “Nutritional Guidance for Patients With Diabetes: Consensus Statement of the Japan Diabetes Society,” Journal of the Japan Diabetes Society
63, no. 3 (2020): 91–109, (in Japanese).</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20Japan%20Diabetes%20Society&amp;title=Nutritional%20Guidance%20for%20Patients%20With%20Diabetes:%20Consensus%20Statement%20of%20the%20Japan%20Diabetes%20Society&amp;author=T.%20Yamauchi&amp;author=H.%20Kamiya&amp;author=K.%20Utsunomiya&amp;volume=63&amp;issue=3&amp;publication_year=2020&amp;pages=91-109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0014">
<span class="label">14.</span><cite>
Umpierrez G. E., Smiley D., Zisman A., et al., “Randomized Study of Basal‐Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial),” Diabetes Care
30, no. 9 (2007): 2181–2186.
</cite> [<a href="https://doi.org/10.2337/dc07-0295" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17513708/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Randomized%20Study%20of%20Basal%E2%80%90Bolus%20Insulin%20Therapy%20in%20the%20Inpatient%20Management%20of%20Patients%20With%20Type%202%20Diabetes%20(RABBIT%202%20Trial)&amp;author=G.%20E.%20Umpierrez&amp;author=D.%20Smiley&amp;author=A.%20Zisman&amp;volume=30&amp;issue=9&amp;publication_year=2007&amp;pages=2181-2186&amp;pmid=17513708&amp;doi=10.2337/dc07-0295&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0015">
<span class="label">15.</span><cite>
Umpierrez G. E., Smiley D., Jacobs S., et al., “Randomized Study of Basal‐Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery),” Diabetes Care
34, no. 2 (2011): 256–261.
</cite> [<a href="https://doi.org/10.2337/dc10-1407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3024330/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21228246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Randomized%20Study%20of%20Basal%E2%80%90Bolus%20Insulin%20Therapy%20in%20the%20Inpatient%20Management%20of%20Patients%20With%20Type%202%20Diabetes%20Undergoing%20General%20Surgery%20(RABBIT%202%20Surgery)&amp;author=G.%20E.%20Umpierrez&amp;author=D.%20Smiley&amp;author=S.%20Jacobs&amp;volume=34&amp;issue=2&amp;publication_year=2011&amp;pages=256-261&amp;pmid=21228246&amp;doi=10.2337/dc10-1407&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0016">
<span class="label">16.</span><cite>
Umpierrez G. E., Smiley D., Hermayer K., et al., “Randomized Study Comparing a Basal‐Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes: Basal Plus Trial,” Diabetes Care
36, no. 8 (2013): 2169–2174.
</cite> [<a href="https://doi.org/10.2337/dc12-1988" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3714500/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23435159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Randomized%20Study%20Comparing%20a%20Basal%E2%80%90Bolus%20With%20a%20Basal%20Plus%20Correction%20Insulin%20Regimen%20for%20the%20Hospital%20Management%20of%20Medical%20and%20Surgical%20Patients%20With%20Type%202%20Diabetes:%20Basal%20Plus%20Trial&amp;author=G.%20E.%20Umpierrez&amp;author=D.%20Smiley&amp;author=K.%20Hermayer&amp;volume=36&amp;issue=8&amp;publication_year=2013&amp;pages=2169-2174&amp;pmid=23435159&amp;doi=10.2337/dc12-1988&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0017">
<span class="label">17.</span><cite>
Fushimi N., Shibuya T., Yoshida Y., Ito S., Hachiya H., and Mori A., “Dulaglutide‐Combined Basal Plus Correction Insulin Therapy Contributes to Ideal Glycemic Control in Non‐Critical Hospitalized Patients,” Journal Diabetes Investig
11, no. 1 (2020): 125–131.</cite> [<a href="https://doi.org/10.1111/jdi.13093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6944833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31168938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20Diabetes%20Investig&amp;title=Dulaglutide%E2%80%90Combined%20Basal%20Plus%20Correction%20Insulin%20Therapy%20Contributes%20to%20Ideal%20Glycemic%20Control%20in%20Non%E2%80%90Critical%20Hospitalized%20Patients&amp;author=N.%20Fushimi&amp;author=T.%20Shibuya&amp;author=Y.%20Yoshida&amp;author=S.%20Ito&amp;author=H.%20Hachiya&amp;volume=11&amp;issue=1&amp;publication_year=2020&amp;pages=125-131&amp;pmid=31168938&amp;doi=10.1111/jdi.13093&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0018">
<span class="label">18.</span><cite>
Kanazawa K., Uchino H., Shigiyama F., et al., “Sustained Fasting Glucose Oxidation and Postprandial Lipid Oxidation Associated With Reduced Insulin Dose in Type 2 Diabetes With Sodium–Glucose Cotransporter 2 Inhibitor: A Randomized, Open‐Label, Prospective Study,” Journal Diabetes Investig
10, no. 4 (2019): 1022–1031.</cite> [<a href="https://doi.org/10.1111/jdi.12994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6626995/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30582774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20Diabetes%20Investig&amp;title=Sustained%20Fasting%20Glucose%20Oxidation%20and%20Postprandial%20Lipid%20Oxidation%20Associated%20With%20Reduced%20Insulin%20Dose%20in%20Type%202%20Diabetes%20With%20Sodium%E2%80%93Glucose%20Cotransporter%202%20Inhibitor:%20A%20Randomized,%20Open%E2%80%90Label,%20Prospective%20Study&amp;author=K.%20Kanazawa&amp;author=H.%20Uchino&amp;author=F.%20Shigiyama&amp;volume=10&amp;issue=4&amp;publication_year=2019&amp;pages=1022-1031&amp;pmid=30582774&amp;doi=10.1111/jdi.12994&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0019">
<span class="label">19.</span><cite>
Kanda Y., “Investigation of the Freely Available Easy‐To‐Use Software ‘EZR’ for Medical Statistics,” Bone Marrow Transplantation
48, no. 3 (2013): 452–458.
</cite> [<a href="https://doi.org/10.1038/bmt.2012.244" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3590441/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23208313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bone%20Marrow%20Transplantation&amp;title=Investigation%20of%20the%20Freely%20Available%20Easy%E2%80%90To%E2%80%90Use%20Software%20%E2%80%98EZR%E2%80%99%20for%20Medical%20Statistics&amp;author=Y.%20Kanda&amp;volume=48&amp;issue=3&amp;publication_year=2013&amp;pages=452-458&amp;pmid=23208313&amp;doi=10.1038/bmt.2012.244&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0020">
<span class="label">20.</span><cite>
Li Y., Xu W., Liao Z., et al., “Induction of Long‐Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients Is Associated With Improvement of β‐Cell Function,” Diabetes Care
27, no. 11 (2004): 2597–2602.
</cite> [<a href="https://doi.org/10.2337/diacare.27.11.2597" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15504992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Induction%20of%20Long%E2%80%90Term%20Glycemic%20Control%20in%20Newly%20Diagnosed%20Type%202%20Diabetic%20Patients%20Is%20Associated%20With%20Improvement%20of%20%CE%B2%E2%80%90Cell%20Function&amp;author=Y.%20Li&amp;author=W.%20Xu&amp;author=Z.%20Liao&amp;volume=27&amp;issue=11&amp;publication_year=2004&amp;pages=2597-2602&amp;pmid=15504992&amp;doi=10.2337/diacare.27.11.2597&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0021">
<span class="label">21.</span><cite>
Kramer C. K., Zinman B., Choi H., and Retnakaran R., “Predictors of Sustained Drug‐Free Diabetes Remission Over 48 Weeks Following Short‐Term Intensive Insulin Therapy in Early Type 2 Diabetes,” BMJ Open Diabetes Research &amp; Care
4, no. 1 (2016): e000270.</cite> [<a href="https://doi.org/10.1136/bmjdrc-2016-000270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4985916/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27547422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open%20Diabetes%20Research%20&amp;%20Care&amp;title=Predictors%20of%20Sustained%20Drug%E2%80%90Free%20Diabetes%20Remission%20Over%2048%E2%80%89Weeks%20Following%20Short%E2%80%90Term%20Intensive%20Insulin%20Therapy%20in%20Early%20Type%202%20Diabetes&amp;author=C.%20K.%20Kramer&amp;author=B.%20Zinman&amp;author=H.%20Choi&amp;author=R.%20Retnakaran&amp;volume=4&amp;issue=1&amp;publication_year=2016&amp;pages=e000270&amp;pmid=27547422&amp;doi=10.1136/bmjdrc-2016-000270&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0022">
<span class="label">22.</span><cite>
Liu L., Ke W., Xu L., et al., “Evaluating the Role of Time in Range as a Glycemic Target During Short‐Term Intensive Insulin Therapy in Patients With Newly Diagnosed Type 2 Diabetes,” Journal of Diabetes
15, no. 2 (2023): 133–144.
</cite> [<a href="https://doi.org/10.1111/1753-0407.13355" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9934958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36650669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Diabetes&amp;title=Evaluating%20the%20Role%20of%20Time%20in%20Range%20as%20a%20Glycemic%20Target%20During%20Short%E2%80%90Term%20Intensive%20Insulin%20Therapy%20in%20Patients%20With%20Newly%20Diagnosed%20Type%202%20Diabetes&amp;author=L.%20Liu&amp;author=W.%20Ke&amp;author=L.%20Xu&amp;volume=15&amp;issue=2&amp;publication_year=2023&amp;pages=133-144&amp;pmid=36650669&amp;doi=10.1111/1753-0407.13355&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0023">
<span class="label">23.</span><cite>
Yanai H., Hakoshima M., and Adachi H., “Which Factor Determines the Duration Required for Relief of Glucotoxicity by the Intensive Insulin Therapy?,” Journal of Clinical Medicine Research
10, no. 8 (2018): 606–608.
</cite> [<a href="https://doi.org/10.14740/jocmr3423w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5997419/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29904447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Medicine%20Research&amp;title=Which%20Factor%20Determines%20the%20Duration%20Required%20for%20Relief%20of%20Glucotoxicity%20by%20the%20Intensive%20Insulin%20Therapy?&amp;author=H.%20Yanai&amp;author=M.%20Hakoshima&amp;author=H.%20Adachi&amp;volume=10&amp;issue=8&amp;publication_year=2018&amp;pages=606-608&amp;pmid=29904447&amp;doi=10.14740/jocmr3423w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0024">
<span class="label">24.</span><cite>
Xu L., Zhang P., Huang Z., et al., “Hypoglycemia During Short‐Term Intensive Insulin Therapy and Its Association With Long‐Term Glycemic Remission in Patients With Newly Diagnosed Type 2 Diabetes,” Journal Diabetes Research
2020 (2020): 4097469.</cite> [<a href="https://doi.org/10.1155/2020/4097469" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7049822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32149152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20Diabetes%20Research&amp;title=Hypoglycemia%20During%20Short%E2%80%90Term%20Intensive%20Insulin%20Therapy%20and%20Its%20Association%20With%20Long%E2%80%90Term%20Glycemic%20Remission%20in%20Patients%20With%20Newly%20Diagnosed%20Type%202%20Diabetes&amp;author=L.%20Xu&amp;author=P.%20Zhang&amp;author=Z.%20Huang&amp;volume=2020&amp;publication_year=2020&amp;pages=4097469&amp;pmid=32149152&amp;doi=10.1155/2020/4097469&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0025">
<span class="label">25.</span><cite>
Tang H., Cui W., Li D., et al., “Sodium‐Glucose Co‐Transporter 2 Inhibitors in Addition to Insulin Therapy for Management of Type 2 Diabetes Mellitus: A Meta‐Analysis of Randomized Controlled Trials,” Diabetes, Obesity &amp; Metabolism
19, no. 2 (2017): 142–147.</cite> [<a href="https://doi.org/10.1111/dom.12785" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27598833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes,%20Obesity%20&amp;%20Metabolism&amp;title=Sodium%E2%80%90Glucose%20Co%E2%80%90Transporter%202%20Inhibitors%20in%20Addition%20to%20Insulin%20Therapy%20for%20Management%20of%20Type%202%20Diabetes%20Mellitus:%20A%20Meta%E2%80%90Analysis%20of%20Randomized%20Controlled%20Trials&amp;author=H.%20Tang&amp;author=W.%20Cui&amp;author=D.%20Li&amp;volume=19&amp;issue=2&amp;publication_year=2017&amp;pages=142-147&amp;pmid=27598833&amp;doi=10.1111/dom.12785&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0026">
<span class="label">26.</span><cite>
Singh A. K. and Singh R., “Sodium‐Glucose Co‐Transporter‐2 Inhibitors as Add‐On Therapy to Insulin: Rationale and Evidences,” Expert Review of Clinical Pharmacology
9, no. 3 (2016): 409–418.
</cite> [<a href="https://doi.org/10.1586/17512433.2016.1131121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26732230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Review%20of%20Clinical%20Pharmacology&amp;title=Sodium%E2%80%90Glucose%20Co%E2%80%90Transporter%E2%80%902%20Inhibitors%20as%20Add%E2%80%90On%20Therapy%20to%20Insulin:%20Rationale%20and%20Evidences&amp;author=A.%20K.%20Singh&amp;author=R.%20Singh&amp;volume=9&amp;issue=3&amp;publication_year=2016&amp;pages=409-418&amp;pmid=26732230&amp;doi=10.1586/17512433.2016.1131121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0027">
<span class="label">27.</span><cite>
Okajima F., Nagamine T., Nakamura Y., Hattori N., Sugihara H., and Emoto N., “Preventive Effect of Ipragliflozin on Nocturnal Hypoglycemia in Patients With Type 2 Diabetes Treated With Basal‐Bolus Insulin Therapy: An Open‐Label, Single‐Center, Parallel, Randomized Control Study,” Journal of Diabetes Investigation
8, no. 3 (2017): 341–345.
</cite> [<a href="https://doi.org/10.1111/jdi.12588" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5415488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27762088/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Diabetes%20Investigation&amp;title=Preventive%20Effect%20of%20Ipragliflozin%20on%20Nocturnal%20Hypoglycemia%20in%20Patients%20With%20Type%202%20Diabetes%20Treated%20With%20Basal%E2%80%90Bolus%20Insulin%20Therapy:%20An%20Open%E2%80%90Label,%20Single%E2%80%90Center,%20Parallel,%20Randomized%20Control%20Study&amp;author=F.%20Okajima&amp;author=T.%20Nagamine&amp;author=Y.%20Nakamura&amp;author=N.%20Hattori&amp;author=H.%20Sugihara&amp;volume=8&amp;issue=3&amp;publication_year=2017&amp;pages=341-345&amp;pmid=27762088&amp;doi=10.1111/jdi.12588&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0028">
<span class="label">28.</span><cite>
Ólafsdóttir A. F., Attvall S., Sandgren U., et al., “A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults With Type 1 Diabetes,” Diabetes Technology &amp; Therapeutics
19, no. 3 (2017): 164–172.
</cite> [<a href="https://doi.org/10.1089/dia.2016.0392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5359691/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28263665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Technology%20&amp;%20Therapeutics&amp;title=A%20Clinical%20Trial%20of%20the%20Accuracy%20and%20Treatment%20Experience%20of%20the%20Flash%20Glucose%20Monitor%20FreeStyle%20Libre%20in%20Adults%20With%20Type%201%20Diabetes&amp;author=A.%20F.%20%C3%93lafsd%C3%B3ttir&amp;author=S.%20Attvall&amp;author=U.%20Sandgren&amp;volume=19&amp;issue=3&amp;publication_year=2017&amp;pages=164-172&amp;pmid=28263665&amp;doi=10.1089/dia.2016.0392&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0029">
<span class="label">29.</span><cite>
Lupsa B. C., Kibbey R. G., and Inzucchi S. E., “Ketones: The Double‐Edged Sword of SGLT2 Inhibitors?,” Diabetologia
66, no. 1 (2023): 23–32.
</cite> [<a href="https://doi.org/10.1007/s00125-022-05815-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36255460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Ketones:%20The%20Double%E2%80%90Edged%20Sword%20of%20SGLT2%20Inhibitors?&amp;author=B.%20C.%20Lupsa&amp;author=R.%20G.%20Kibbey&amp;author=S.%20E.%20Inzucchi&amp;volume=66&amp;issue=1&amp;publication_year=2023&amp;pages=23-32&amp;pmid=36255460&amp;doi=10.1007/s00125-022-05815-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0030">
<span class="label">30.</span><cite>
Ferrannini E., Baldi S., Frascerra S., et al., “Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes,” Diabetes
65, no. 5 (2016): 1190–1195.
</cite> [<a href="https://doi.org/10.2337/db15-1356" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26861783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Shift%20to%20Fatty%20Substrate%20Utilization%20in%20Response%20to%20Sodium%E2%80%93Glucose%20Cotransporter%202%20Inhibition%20in%20Subjects%20Without%20Diabetes%20and%20Patients%20With%20Type%202%20Diabetes&amp;author=E.%20Ferrannini&amp;author=S.%20Baldi&amp;author=S.%20Frascerra&amp;volume=65&amp;issue=5&amp;publication_year=2016&amp;pages=1190-1195&amp;pmid=26861783&amp;doi=10.2337/db15-1356&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0031">
<span class="label">31.</span><cite>
Sharma P. V., Jobanputra Y. B., Lewin K., Bagatell S., and Lichtstein D. M., “Diabetic Ketoacidosis in Patients With Type 2 Diabetes on Sodium‐Glucose Cotransporter‐2 Inhibitors: A Case Series,” Reviews on Recent Clinical Trials
13, no. 2 (2018): 156–160.
</cite> [<a href="https://doi.org/10.2174/1574887113666180314101436" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29542418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Reviews%20on%20Recent%20Clinical%20Trials&amp;title=Diabetic%20Ketoacidosis%20in%20Patients%20With%20Type%202%20Diabetes%20on%20Sodium%E2%80%90Glucose%20Cotransporter%E2%80%902%20Inhibitors:%20A%20Case%20Series&amp;author=P.%20V.%20Sharma&amp;author=Y.%20B.%20Jobanputra&amp;author=K.%20Lewin&amp;author=S.%20Bagatell&amp;author=D.%20M.%20Lichtstein&amp;volume=13&amp;issue=2&amp;publication_year=2018&amp;pages=156-160&amp;pmid=29542418&amp;doi=10.2174/1574887113666180314101436&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0032">
<span class="label">32.</span><cite>
Storgaard H., Bagger J. I., Knop F. K., et al., “Diabetic Ketoacidosis in a Patient With Type 2 Diabetes After Initiation of Sodium–Glucose Cotransporter 2 Inhibitor Treatment,” Basic and Clinical Pharmacology and Toxicology
118, no. 3 (2016): 168–170.
</cite> [<a href="https://doi.org/10.1111/bcpt.12457" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26291182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Basic%20and%20Clinical%20Pharmacology%20and%20Toxicology&amp;title=Diabetic%20Ketoacidosis%20in%20a%20Patient%20With%20Type%202%20Diabetes%20After%20Initiation%20of%20Sodium%E2%80%93Glucose%20Cotransporter%202%20Inhibitor%20Treatment&amp;author=H.%20Storgaard&amp;author=J.%20I.%20Bagger&amp;author=F.%20K.%20Knop&amp;volume=118&amp;issue=3&amp;publication_year=2016&amp;pages=168-170&amp;pmid=26291182&amp;doi=10.1111/bcpt.12457&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0033">
<span class="label">33.</span><cite>
Goldenberg R. M., Berard L. D., Cheng A. Y. Y., et al., “SGLT2 Inhibitor–Associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis,” Clinical Therapeutics
38, no. 12 (2016): 2654–2664.e1.
</cite> [<a href="https://doi.org/10.1016/j.clinthera.2016.11.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28003053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Therapeutics&amp;title=SGLT2%20Inhibitor%E2%80%93Associated%20Diabetic%20Ketoacidosis:%20Clinical%20Review%20and%20Recommendations%20for%20Prevention%20and%20Diagnosis&amp;author=R.%20M.%20Goldenberg&amp;author=L.%20D.%20Berard&amp;author=A.%20Y.%20Y.%20Cheng&amp;volume=38&amp;issue=12&amp;publication_year=2016&amp;pages=2654-2664.e1&amp;pmid=28003053&amp;doi=10.1016/j.clinthera.2016.11.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0034">
<span class="label">34.</span><cite>
Harris S., Mequanint S., Miller K., Reichert S., and Spaic T., “When Insulin Therapy Fails: The Impact of SGLT2 Inhibitors in Patients With Type 2 Diabetes,” Diabetes Care
40, no. Suppl 1 (2017): S109.</cite> [<a href="https://doi.org/10.2337/dc17-0744" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28765274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=When%20Insulin%20Therapy%20Fails:%20The%20Impact%20of%20SGLT2%20Inhibitors%20in%20Patients%20With%20Type%202%20Diabetes&amp;author=S.%20Harris&amp;author=S.%20Mequanint&amp;author=K.%20Miller&amp;author=S.%20Reichert&amp;author=T.%20Spaic&amp;volume=40&amp;issue=Suppl%201&amp;publication_year=2017&amp;pages=S109&amp;pmid=28765274&amp;doi=10.2337/dc17-0744&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0035">
<span class="label">35.</span><cite>
Yang Y., Zhao C., Ye Y., Yu M., and Qu X., “Prospect of Sodium–Glucose Co‐Transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes,” Frontiers in Endocrinology
11 (2020): 589702, 10.3389/fendo.2020.589702.</cite> [<a href="https://doi.org/10.3389/fendo.2020.589702" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7174744/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32351447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Endocrinology&amp;title=Prospect%20of%20Sodium%E2%80%93Glucose%20Co%E2%80%90Transporter%202%20Inhibitors%20Combined%20With%20Insulin%20for%20the%20Treatment%20of%20Type%202%20Diabetes&amp;author=Y.%20Yang&amp;author=C.%20Zhao&amp;author=Y.%20Ye&amp;author=M.%20Yu&amp;author=X.%20Qu&amp;volume=11&amp;publication_year=2020&amp;pages=589702&amp;pmid=32351447&amp;doi=10.3389/fendo.2020.589702&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0036">
<span class="label">36.</span><cite>
Yang T., Zhou Y., and Cui Y., “Urinary Tract Infections and Genital Mycotic Infections Associated With SGLT2 Inhibitors: An Analysis of the FDA Adverse Event Reporting System,” Expert Opinion on Drug Safety
23, no. 2 (2024): 1035–1040.
</cite> [<a href="https://doi.org/10.1080/14740338.2023.2288897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38009230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opinion%20on%20Drug%20Safety&amp;title=Urinary%20Tract%20Infections%20and%20Genital%20Mycotic%20Infections%20Associated%20With%20SGLT2%20Inhibitors:%20An%20Analysis%20of%20the%20FDA%20Adverse%20Event%20Reporting%20System&amp;author=T.%20Yang&amp;author=Y.%20Zhou&amp;author=Y.%20Cui&amp;volume=23&amp;issue=2&amp;publication_year=2024&amp;pages=1035-1040&amp;pmid=38009230&amp;doi=10.1080/14740338.2023.2288897&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="edm270096-bib-0037">
<span class="label">37.</span><cite>
Yang H., Choi E., Park E., et al., “Risk of Genital and Urinary Tract Infections Associated With SGLT‐2 Inhibitors as an Add‐On Therapy to Metformin in Patients With Type 2 Diabetes Mellitus: A Retrospective Cohort Study in Korea,” Pharmacology Research &amp; Perspectives
10, no. 5 (2022): e00910.
</cite> [<a href="https://doi.org/10.1002/prp2.910" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8929338/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35005849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20Research%20&amp;%20Perspectives&amp;title=Risk%20of%20Genital%20and%20Urinary%20Tract%20Infections%20Associated%20With%20SGLT%E2%80%902%20Inhibitors%20as%20an%20Add%E2%80%90On%20Therapy%20to%20Metformin%20in%20Patients%20With%20Type%202%20Diabetes%20Mellitus:%20A%20Retrospective%20Cohort%20Study%20in%20Korea&amp;author=H.%20Yang&amp;author=E.%20Choi&amp;author=E.%20Park&amp;volume=10&amp;issue=5&amp;publication_year=2022&amp;pages=e00910&amp;pmid=35005849&amp;doi=10.1002/prp2.910&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Due to the nature of this research, the study participants did not agree for their data to be shared publicly; as such, supporting data is not available.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Endocrinology, Diabetes &amp; Metabolism are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/edm2.70096"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/EDM2-8-e70096.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (267.2 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12364101/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12364101/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12364101%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364101/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12364101/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12364101/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40828947/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12364101/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40828947/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12364101/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12364101/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="c7lKfjDQ3zc8xAgNWlvQxxm6qyd2i95LMi9wnYvx4VZVRSu13onT0TKWug5eb4bs">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
